Vertex Pharmaceuticals (VRTX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

Is VRTX a good stock to buy? We came across a bullish thesis on Vertex Pharmaceuticals Incorporated on r/AIPortfolios by ...

A new product approval may be right around the corner.

Vertex Pharmaceuticals now carries a fair value estimate of US$547.72, compared with the prior US$504.04, as analysts refresh ...

Everyone should save money for retirement, since programs such as Social Security aren't meant to replace workers' entire ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks among the best high profit margin stocks to buy. On March 10, Truist ...

March 9 (Reuters) - Vertex Pharmaceuticals said on Monday that its experimental kidney disease drug met the main goal of a late-stage trial. Shares of the company were up about 10% in extended trading ...

Vertex Pharmaceuticals said its drug for a rare kidney condition succeeded in a Phase 3 trial.

Both have plenty to offer investors, but one has a better outlook.

Interim results from RAINIER reveal that an 80 mg dose of povetacicept every four weeks delivered a 52% reduction in protein ...

Investing.com -- Vertex Pharmaceuticals (NASDAQ:VRTX) shares rose 6% to $488.52 in premarket trading Thursday after the company reported successful results from a late-stage trial of its kidney ...